Skip to content
Article Rich – Lifestyle
Author:
GOA Therapeutics Corporation
GOA Therapeutics Files with SEC for Proposed Public Offering, Contemplates Issuing Up to $300 Million in Stock
September 30, 2026
GOA Therapeutics Emerges from Stealth with $15.5 Million in Funding and Unveils GOA26, a First-in-Class Drug Candidate for Acute Alcohol Intoxication and Poisoning
September 17, 2026